By Ed Silverman | Nov. 18, 2026
In a milestone that marks the conclusion of a decadelong ethical transition, the National Institutes of Health (NIH) announced this week that the final chimpanzees under federal ownership currently residing in a laboratory setting will be relocated to a sanctuary. The move effectively shutters the last vestige of a practice that once defined the landscape of American biomedical research but has increasingly been viewed as scientifically unnecessary and morally untenable.
Beginning in early 2027, approximately three dozen chimpanzees currently housed at the Keeling Center for Comparative Medicine and Research in Bastrop, Texas, will begin their journey to Chimp Haven in Keithville, Louisiana. The 200-acre federal sanctuary, the only facility of its kind in the United States, will provide a permanent home for these animals, offering them a life outside of laboratory enclosures.
"Completing their transfers will fulfill the NIH’s commitment, announced in November 2015, to retire all NIH-owned chimpanzees to sanctuary," said NIH Director Jay Bhattacharya in a formal statement. This relocation represents the final fulfillment of a policy shift that sent shockwaves through the scientific community eleven years ago.
A Chronology of Change: From Lab to Sanctuary
The trajectory toward this week’s announcement was not linear; it was the result of intense political pressure, shifting scientific paradigms, and evolving societal ethics regarding animal welfare.
- The Early 2000s: Public scrutiny of chimpanzee research intensified as animal welfare organizations highlighted the psychological trauma experienced by primates in captivity.
- 2011: A landmark report from the Institute of Medicine (IOM) concluded that most biomedical research on chimpanzees was unnecessary. This provided the intellectual framework for regulators to begin scaling back research.
- 2013: The NIH announced it would retire the vast majority of its research chimpanzees, keeping only a small population for potential future needs.
- November 2015: In a watershed moment, then-NIH Director Francis Collins announced that the agency would end all support for biomedical research on chimpanzees, declaring that the era of using our closest evolutionary relatives for such studies had effectively ended.
- 2016–2025: A slow, logistically complex process of "retirement" ensued. Many chimpanzees were elderly or suffered from health conditions that made the physical transition to sanctuaries difficult, requiring specialized care and slow integration.
- November 2026: The NIH confirms the final group of roughly 35 chimpanzees at the Keeling Center is cleared for transport to Chimp Haven.
Supporting Data: Why the Research Stopped
The pivot away from chimpanzee research was fueled by both ethics and cold, hard science. As genomics and biotechnology advanced, the need for chimpanzee models diminished significantly.
Historically, chimpanzees were used for the development of vaccines—most notably for Hepatitis C—and to study infectious diseases. However, the development of "in vitro" models, human-cell-based organoids, and advanced computer modeling rendered the use of primates less essential.
Furthermore, the data showed that chimpanzees are highly social, sentient beings capable of suffering. The psychological toll of laboratory housing—characterized by small cages and social isolation—was increasingly recognized as a significant confounding variable in scientific studies. The realization that "better science" could be achieved through non-animal methods created a consensus among researchers that the ethical cost was simply too high.

Official Responses and Ethical Reflections
The decision to move the final residents of the Keeling Center has been met with praise from the scientific community and animal welfare advocates alike.
"This is the end of a long, arduous process," said a spokesperson for a leading animal rights advocacy group. "While it took longer than many of us hoped, the fact that these animals will spend their final years in a naturalistic setting is a testament to the fact that our culture has evolved."
Within the NIH, the perspective has shifted from viewing chimpanzees as "research subjects" to "retirees." The logistical challenge of moving these animals is immense; they require specialized transport, veterinary oversight, and a gradual introduction to the social hierarchy of the existing Chimp Haven population.
Director Bhattacharya’s statement underscored the complexity of the operation: "The welfare of these animals is our primary concern. We have worked closely with the team at Chimp Haven to ensure that the transition is as seamless and stress-free as possible for the chimps."
Implications for the Future of Biomedical Research
The total retirement of NIH-owned chimpanzees signals a permanent change in the regulatory and ethical landscape of American research.
The End of Primates in Testing?
While this announcement specifically addresses chimpanzees, the ripple effects are being felt across the entire spectrum of animal research. The "3Rs" (Replacement, Reduction, and Refinement) have become the gold standard for institutional animal care and use committees (IACUCs). Funding bodies are increasingly prioritizing research proposals that utilize human-derived tissues or synthetic biology over traditional animal models.
The Financial Burden of Sanctuary
A significant, and often overlooked, implication is the financial burden of "retirement." Chimpanzees can live for several decades, and providing high-quality sanctuary care is expensive. The NIH continues to be the primary funding source for Chimp Haven, a cost that will persist for years to come. This creates an ongoing fiscal responsibility for the government, serving as a reminder that the cost of research extends far beyond the duration of the laboratory study itself.
A Global Benchmark
The United States was one of the last developed nations to rely on chimpanzees for research. By closing the Keeling Center’s program, the U.S. aligns itself with a global consensus that has largely prohibited such research in Europe and other parts of the world. This move bolsters the American position in international scientific ethics debates, potentially influencing future policies on other species, such as rhesus macaques, which remain heavily used in research today.

Challenges of the Final Transfer
The final group of chimps at the Keeling Center presents unique challenges. Many are "seniors" in the primate world, some with pre-existing conditions related to their years in research environments. The move to Louisiana involves a significant logistical operation: specialized trailers, climate control, and a team of veterinarians prepared for emergencies.
At Chimp Haven, the new arrivals will undergo a "quarantine and acclimation" period. The sanctuary is designed to mirror a natural habitat, allowing the chimpanzees to engage in complex social behaviors, foraging, and climbing—activities that were impossible in their previous laboratory settings. For many, this will be the first time they have experienced sunlight, grass, and a true social hierarchy in their adult lives.
Conclusion: A New Standard
The retirement of the last NIH-owned chimpanzees is more than just a bureaucratic milestone; it is the closing of a chapter on a methodology that once defined 20th-century medicine. It serves as a case study in how public opinion, combined with technological advancement and ethical introspection, can force a change in the way a nation approaches scientific inquiry.
As the last few chimpanzees make their way to Louisiana, the research community is looking toward a future where the necessity of animal models is constantly challenged. The legacy of these animals—who contributed to major breakthroughs in human health—will now be one of retirement and, finally, the simple freedom to exist as they are.
For the NIH, the task is now to ensure that the sanctuary model remains well-funded and sustainable, honoring the debt owed to these animals. For the broader scientific community, the question remains: what is the next frontier of non-animal research, and how quickly can we embrace the innovations that will make the use of other sentient beings in laboratories as obsolete as chimpanzee research has become?
As we look toward 2027, the focus shifts from the laboratory bench to the sanctuary forest, where these final retirees will spend their remaining years. It is a quiet, dignified end to a long and complex history—a victory for those who argued that the cost of progress should never be the sacrifice of our closest animal kin.
